Elevation Point Wealth Partners LLC Acquires New Shares in Astera Labs, Inc. $ALAB

Elevation Point Wealth Partners LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 1st quarter, Holdings Channel.com reports. The firm acquired 11,088 shares of the company’s stock, valued at approximately $1,215,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Patten Group Inc. bought a new position in shares of Astera Labs during the 1st quarter valued at about $371,000. Strs Ohio raised its holdings in shares of Astera Labs by 996.3% during the first quarter. Strs Ohio now owns 33,086 shares of the company’s stock worth $3,626,000 after acquiring an additional 30,068 shares during the period. Essex Financial Services Inc. raised its holdings in shares of Astera Labs by 4.2% during the first quarter. Essex Financial Services Inc. now owns 27,169 shares of the company’s stock worth $2,978,000 after acquiring an additional 1,086 shares during the period. IFM Investors Pty Ltd lifted its position in Astera Labs by 5.9% in the 1st quarter. IFM Investors Pty Ltd now owns 26,195 shares of the company’s stock valued at $2,871,000 after acquiring an additional 1,469 shares in the last quarter. Finally, Redwood Wealth Management Group LLC lifted its position in Astera Labs by 17.0% in the 1st quarter. Redwood Wealth Management Group LLC now owns 2,610 shares of the company’s stock valued at $286,000 after acquiring an additional 380 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Stock Performance

ALAB opened at $432.74 on Tuesday. Astera Labs, Inc. has a 52-week low of $88.18 and a 52-week high of $499.48. The firm has a market capitalization of $74.18 billion, a PE ratio of 292.39, a PEG ratio of 4.66 and a beta of 3.66. The business’s 50-day simple moving average is $314.72 and its 200 day simple moving average is $205.99.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ALAB. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Morgan Stanley lifted their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Citigroup cut Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, Susquehanna upped their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $265.75.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the transaction, the director owned 286,863 shares in the company, valued at approximately $131,492,261.94. The trade was a 2.87% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,164,441 shares of company stock worth $526,198,280 in the last quarter. 10.40% of the stock is owned by company insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.